
|Videos|December 23, 2020
R/R Multiple Myeloma: Review of the CARTITUDE Trial
Author(s)Targeted Oncology
Recent updates from the ASH 2020 annual meeting on the phase 1b/2 CARTITUDE-1 trial for relapsed/refractory multiple myeloma.
Recent updates from the ASH 2020 annual meeting on the phase 1b/2 CARTITUDE-1 trial for relapsed/refractory multiple myeloma.